Emrusolmin is expected to improve symptoms of MSA by targeting alpha synuclein oligomers. The Food and Drug Administration (FDA) has granted Fast Track designation to emrusolmin (TEV-56286) for the ...

Currently no disease-modifying or neuroprotective treatments exist for MSA, nor are there effective medications to treat the cerebellar ataxia in MSA-C or the parkinsonian features in MSA-P. Physical ...

An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...

This week an international team of astronomers reports the first multiple-star system to be observed during the earliest stage of formation. This finding supports model predictions about how two- and ...

In 2026, AI agents are being widely used. OpenClaw has become a high-frequency efficiency improvement tool for enterprises and developers with its autonomous decision-making and local execution ...

Vicon Industries, a subsidiary of Cemtrex Inc., has launched its NEXT Modular Sensor System, which has quickly gained recognition in the security industry, winning multiple awards including an ...